Phagelux Announces Acquisition of Omnilytics

22-Jul-2015 - USA
Phagelux, Inc., a leading anti-bacterial company, announced the purchase of OmniLytics, Inc., headquartered in Salt Lake City, a pioneer in the research and development of bacteriophage solutions for pathogen control in the fields of agriculture, food and water safety, and sanitation.    
OmniLytics has several category products including a line of treatments for bacterial diseases in agriculture, which are marketed under the AgriPhage brand as well as several food safety products sold by partners under their respective brands.
Mark Engel, Chairman of Phagelux, says "We are extremely excited to have the OmniLytics team join our organization. They bring with them great science, first-class product development capabilities, and US manufacturing presence."  Mr. Engel adds that "there is also great synergy between the OmniLytics products and our own AgriHealth lines."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances